Immunosuppressants for therapy of patients with ulcerative colitis

Tadakazu Hisamatsu, Toshifumi Hibi

Research output: Contribution to journalArticle

Abstract

Ulcerative colitis (UC) has been known as inflammatory bowel disease. Progress in UC management strategies has led to optimized approaches for achieving the two primary clinical goals of therapy: induction and maintenance of remission. We here review about immunosuppressants in management of UC; Cyclosporine A (CsA) has been used for the induction therapy in steroid resistant refractory UC. Although it has been reported that CsA has high response rate in severe UC, long-term efficacy (maintenance of remission) has not been proven. To improve maintenance therapy, immunosuppressant has been re-considered in management of UC. In recent years, it has been reported that efficacy of 6-mercaptopurine/azathioprine in maintenance of remission of UC is superior to 5-aminosalicylate (5-ASA). Pharmacological studies have indicated thiopurine methyltransferase (TPMT) activity is essential for maintenance of blood concentration of 6-thioguanine nucleotide (6-TG).

Original languageEnglish
Pages (from-to)831-835
Number of pages5
JournalNippon rinsho. Japanese journal of clinical medicine
Volume63
Issue number5
Publication statusPublished - 2005

Fingerprint

Immunosuppressive Agents
Ulcerative Colitis
Maintenance
thiopurine methyltransferase
Therapeutics
Cyclosporine
Remission Induction
Mesalamine
6-Mercaptopurine
Azathioprine
Inflammatory Bowel Diseases
Steroids
Pharmacology

Cite this

Immunosuppressants for therapy of patients with ulcerative colitis. / Hisamatsu, Tadakazu; Hibi, Toshifumi.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 63, No. 5, 2005, p. 831-835.

Research output: Contribution to journalArticle

Hisamatsu, Tadakazu ; Hibi, Toshifumi. / Immunosuppressants for therapy of patients with ulcerative colitis. In: Nippon rinsho. Japanese journal of clinical medicine. 2005 ; Vol. 63, No. 5. pp. 831-835.
@article{c8e53befaef14d68a15df87d354d4fc8,
title = "Immunosuppressants for therapy of patients with ulcerative colitis",
abstract = "Ulcerative colitis (UC) has been known as inflammatory bowel disease. Progress in UC management strategies has led to optimized approaches for achieving the two primary clinical goals of therapy: induction and maintenance of remission. We here review about immunosuppressants in management of UC; Cyclosporine A (CsA) has been used for the induction therapy in steroid resistant refractory UC. Although it has been reported that CsA has high response rate in severe UC, long-term efficacy (maintenance of remission) has not been proven. To improve maintenance therapy, immunosuppressant has been re-considered in management of UC. In recent years, it has been reported that efficacy of 6-mercaptopurine/azathioprine in maintenance of remission of UC is superior to 5-aminosalicylate (5-ASA). Pharmacological studies have indicated thiopurine methyltransferase (TPMT) activity is essential for maintenance of blood concentration of 6-thioguanine nucleotide (6-TG).",
author = "Tadakazu Hisamatsu and Toshifumi Hibi",
year = "2005",
language = "English",
volume = "63",
pages = "831--835",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "5",

}

TY - JOUR

T1 - Immunosuppressants for therapy of patients with ulcerative colitis

AU - Hisamatsu, Tadakazu

AU - Hibi, Toshifumi

PY - 2005

Y1 - 2005

N2 - Ulcerative colitis (UC) has been known as inflammatory bowel disease. Progress in UC management strategies has led to optimized approaches for achieving the two primary clinical goals of therapy: induction and maintenance of remission. We here review about immunosuppressants in management of UC; Cyclosporine A (CsA) has been used for the induction therapy in steroid resistant refractory UC. Although it has been reported that CsA has high response rate in severe UC, long-term efficacy (maintenance of remission) has not been proven. To improve maintenance therapy, immunosuppressant has been re-considered in management of UC. In recent years, it has been reported that efficacy of 6-mercaptopurine/azathioprine in maintenance of remission of UC is superior to 5-aminosalicylate (5-ASA). Pharmacological studies have indicated thiopurine methyltransferase (TPMT) activity is essential for maintenance of blood concentration of 6-thioguanine nucleotide (6-TG).

AB - Ulcerative colitis (UC) has been known as inflammatory bowel disease. Progress in UC management strategies has led to optimized approaches for achieving the two primary clinical goals of therapy: induction and maintenance of remission. We here review about immunosuppressants in management of UC; Cyclosporine A (CsA) has been used for the induction therapy in steroid resistant refractory UC. Although it has been reported that CsA has high response rate in severe UC, long-term efficacy (maintenance of remission) has not been proven. To improve maintenance therapy, immunosuppressant has been re-considered in management of UC. In recent years, it has been reported that efficacy of 6-mercaptopurine/azathioprine in maintenance of remission of UC is superior to 5-aminosalicylate (5-ASA). Pharmacological studies have indicated thiopurine methyltransferase (TPMT) activity is essential for maintenance of blood concentration of 6-thioguanine nucleotide (6-TG).

UR - http://www.scopus.com/inward/record.url?scp=20644465202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20644465202&partnerID=8YFLogxK

M3 - Article

C2 - 15881178

AN - SCOPUS:20644465202

VL - 63

SP - 831

EP - 835

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 5

ER -